These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32947556)

  • 1. Impact of Therapeutic Drug Monitoring on Once-Daily Regimen of Amikacin in Patients With Urinary Tract Infection: A Prospective Observational Study.
    Jayakumar I; Mathaiyan J; Mandal J; Deepanjali S; Sreenivasan SK
    Ther Drug Monit; 2020 Dec; 42(6):841-847. PubMed ID: 32947556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
    Giamarellou H; Yiallouros K; Petrikkos G; Moschovakis E; Vavouraki E; Voutsinas D; Sfikakis P
    J Antimicrob Chemother; 1991 May; 27 Suppl C():73-9. PubMed ID: 1906864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients.
    Ruiz J; Ramirez P; Company MJ; Gordon M; Villarreal E; Concha P; Aroca M; Frasquet J; Remedios-Marqués M; Castellanos-Ortega Á
    J Glob Antimicrob Resist; 2018 Mar; 12():90-95. PubMed ID: 29017888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder.
    Amasyali AS; Yilmaz D; Yilmaz M; Kucukdurmaz F; Sonmez F; Erol H
    Int Urol Nephrol; 2017 Dec; 49(12):2105-2109. PubMed ID: 28956280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
    Vaidyanathan S; Peloquin C; Wyndaele JJ; Buczynski AZ; Almog Y; Markantonis SL; Jayawardena V; Soni BM; Cannon J; Vidal J
    ScientificWorldJournal; 2006 Feb; 6():187-99. PubMed ID: 16493523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.
    Williams PJ; Hull JH; Sarubbi FA; Rogers JF; Wargin WA
    J Clin Pharmacol; 1986 Feb; 26(2):79-86. PubMed ID: 3950060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
    Jenkins A; Thomson AH; Brown NM; Semple Y; Sluman C; MacGowan A; Lovering AM; Wiffen PJ;
    J Antimicrob Chemother; 2016 Oct; 71(10):2754-9. PubMed ID: 27494904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children.
    Medjebeur Hanna R; Levy M; Bille E; Hennequin C; Lesage F; Naudin J; Moulin F; Blanquer M; Béranger A; Renolleau S; Oualha M; Genuini M
    Paediatr Drugs; 2021 Jul; 23(4):395-401. PubMed ID: 34142330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
    Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
    J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates.
    Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M
    J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients.
    Marik PE; Lipman J; Kobilski S; Scribante J
    J Antimicrob Chemother; 1991 Nov; 28(5):753-64. PubMed ID: 1778878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside dosages and nephrotoxicity: quantitative relationships.
    Rougier F; Ducher M; Maurin M; Corvaisier S; Claude D; Jelliffe R; Maire P
    Clin Pharmacokinet; 2003; 42(5):493-500. PubMed ID: 12739987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.